Local Institution

Bari 70126

0 studies enrolling now · 13 studies all time

What they study most

AIDS, Arthritis, Rheumatoid, Breast Cancer, Cancer, Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, HIV Infections, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Multiple Myeloma, Myeloid Leukemia, Chronic, Accelerated Phase, Myeloid Leukemia, Chronic, Chronic-Phase, Philadelphia-Positive Myeloid Leukemia

Studies at this site

• Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib — Completed
• Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed
• A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma — Stopped early
• Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) — Completed
• Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML — Completed
• Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients — Completed
• Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML — Completed
• Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib — Completed
• Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed